Purchase Order 75N95023P00579
Award Date 8/18/23
Potential Completion Date 9/18/23
Potential Value $85K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of cryopreserved human hepatocytes, which are used to support biomedical research, medical readiness, and other federal initiatives. The contract has a ceiling value of $127,649.76 and a completion date of August 7, 2020. Life Technologies serves as a prime contractor...
- This is a $90,414 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for a Liver Assay in Liver Spheroids to evaluate the toxicity of short interfering RNA (siRNA) and antisense oligonucleotides (ASOs), which are increasingly being used as...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $45,717 firm fixed price purchase order to Xenotech LLC, doing business as Sekisui-Xenotech, for the provision of cryopreserved human, mouse, and rat hepatocytes. The solicitation sought these hepatocytes for use in drug metabolism experiments to support the National Institute on Drug Abuse's malaria research project and understand drug metabolism in...
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
- This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to BioIVT, LLC for the procurement of various Hepatopac sample well plates, including human, mouse, and stromal plates, as well as maintenance and application media. The total ceiling value of the contract is $27,249.00, with an anticipated 60-day delivery after receipt of order. The purchase order was awarded on a...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Discovery Life Sciences, LLC, a small disadvantaged business, on August 2, 2022. The contract has a ceiling value of $48,945.00 and a completion date of November 1, 2022. The contract is for the procurement of primary human hepatocytes and media, as requested in the FDA's Sources Sought Notice FDA-SSN-1252684. Discovery Life Sciences has over a decade of experience supporting federal agencies'...
- The Department of Health and Human Services Food and Drug Administration awarded a $47,945 purchase order to Discovery Life Sciences, LLC for human primary hepatocytes, recovery, plating, and induction media. This firm fixed price contract supports the FDA's research and development efforts through the delivery of human liver cells and associated media. Discovery Life Sciences will perform the work in Huntsville, Alabama under the total small business set aside designation. No major...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Bioivt, LLC for $15,000.00 on September 8, 2020, for male human cryoplateable hepatocytes (5 million, Lot BGW, from reserve stock). Performance occurs in Westbury, New York. The order is firm fixed price with an ultimate completion date of October 8, 2020.</p>
- The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
- This is a $18,166 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Bioivt, LLC, a for-profit limited liability company, for the delivery of human and mouse hepatopac plates. The contract has a period of performance through November 2, 2024 and was not set aside for any particular business type. Bioivt is a leading global provider of biological specimens and has supported medical research programs across various...